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Accepted 28 July 1997Pentobarbital-anaesthetized male Wistar rats were
infused with 6 m g kg- 1 min- 1 of noradrenaline. The infusion
was supplemented with 8.5 mg kg- 1 min- 1 of D-3-
hydroxybutyrate (3-OHB) for 15 min in order to determine
its effect on the adrenergic response of the rat. Plasma
levels of noradrenaline rose to a plateau of approximately
50 nmol l- 1 with infusion. In the group infused with
noradrenaline alone, noradrenaline levels were maintained
for 1 h. Supplementation with 3-OHB induced a decrease
in plasma noradrenaline level that was inversely correlated
with 3-OHB level. Aortic and interscapular brown adipose
tissue temperatures increased with noradrenaline infusion,
but the rise was arrested by 3-OHB; replacing 3-OHB with
glucose had no effect. Infusion of saline, glucose or 3-OHB
in the absence of noradrenaline did not induce a rise in
temperature in either tissue. Blood 3-OHB concentration
increased to 1.2 mmol l- 1 during 3-OHB infusion,
decreasing rapidly at the end of infusion. Blood glucose
levels increased with noradrenaline infusion; the presence
of high 3-OHB levels decreased glucose concentration. The
effects observed were transient and dependent on 3-OHB
concentration; these effects may help explain most of the
other effects of noradrenaline described here. The role of
3-OHB as a regulator of adrenergic responses seems to be
part of a complex fail-safe mechanism which prevents
wasting.
Key words: 3-hydroxybutyrate, ketone bodies, thermogenesis,
noradrenaline, brown adipose tissue, body temperature, rat.
SummaryAdaptive thermogenesis by brown adipose tissue (BAT) is
directly related to noradrenergic stimulation (Foster and
Frydman, 1978), both under cold-exposure (Foster and
Frydman, 1979) or when excess energy is available (Rothwell
and Stock, 1979). Continuous infusion of rats with
catecholamines results in increased heat production and a rise
in blood temperature (Hugie et al. 1992; Zylan and Carlisle,
1992) as a consequence of the stimulation of BAT (Trayhurn
and Ashwell, 1987). The effects of noradrenaline infusion
include increases in circulating glucose levels (Nikami et al.
1992), basically a consequence of massive glycogen
breakdown (Shiota et al. 1992), as well as marked changes in
blood flow distribution and cardiac output (Gordon, 1990).
Ketone bodies are synthesized by the liver under conditions
of scarce glucose combined with marked lipolysis and the
consequent availability of fatty acids (Ubukata et al. 1992).
Ketone bodies are produced during starvation (Balasse, 1979;
Balasse and Féry, 1989), diabetes (Sherwin et al. 1976; Féry
and Balasse, 1985; Balasse and Féry, 1989) or the consumption
of fatty low-carbohydrate (ketogenic) diets (Ide et al. 1984).
Introduction*Author for correspondence (e-mail: alemany@porthos.bio.ub.es).The large change in blood levels of 3-hydroxybutyrate (3-
OHB) and acetoacetate from the basal to the ketotic condition
means that these levels may be a signal to determine which
substrates are oxidized (Hetenyi and Ferraroto, 1985; Ohmori
et al. 1990; Metcalfe et al. 1992). It has been found that 3-
OHB acts as a signal that limits BAT substrate oxidation and
thermogenesis (Pokasanieva et al. 1993), thus preventing
unwanted wastage of substrates under conditions of starvation
or altered substrate utilization (De Pergola et al. 1990). This
effect occurs through modulation of the response of BAT
(Pokasanieva et al. 1993), but also by a direct interaction
between 3-OHB and adrenergic receptors (De Pergola et al.
1990). The results presented here show the direct effects of 3-
OHB on anaesthetized rats constantly infused with
noradrenaline.
Materials and methods
Two-month-old male Wistar rats (from Charles River,
France) weighing 240–260 g were used. The animals were kept
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Horts, Spain), illumination (light on from 08:00 to 20:00 h),
temperature (21–22 °C) and humidity (70 %) in individual
polypropylene-bottomed cages until the experiments were
performed. All experiments took place between 08:00 and
10:00 h. The rats were anaesthetized with an intraperitoneal
injection of 50 mg kg- 1 sodium pentobarbital (Sigma, St Louis,
MO, USA) in 9 g l- 1 NaCl. The rats were then placed in a
chamber with the temperature controlled at 28–30 °C. Two K-
type thermocouple temperature probes (Kane May, Welwyn
Garden City, Herts, UK) were inserted, one on the lower aorta
wall and the other between the interscapular BAT masses, as
described previously (Closa et al. 1993). The probes were
connected to a Data logger (type KM-1420, from Kane May)
which recorded temperatures at 10 s intervals. These data were
converted into 3 min means in order to allow comparisons
between series of rats.
The lower vena cava was then cannulated using P10
polyethylene catheter tubing (Clay Adams, Parsipanny, NJ,
USA) for continuous infusion. A second cannula was also
placed on the lower vena cava, more distal with respect to the
heart, and filled with heparinized saline to keep it functional
for sampling.
The infusion apparatus consisted of a slow infusion syringe
pump (Precidor 5003, Infors AG, Bottmingen, Germany) filled
with saline; the saline was injected at a rate of 4 ml h- 1 kg- 1.
The syringe efflux was distributed by a Y-piece into two
containers filled with 280 m mol l- 1 L-(+)-noradrenaline
bitartrate (Sigma) in 9 g l- 1 NaCl; one of these contained, in
addition, 1 mol l- 1 D-(- )-3-hydroxybutyric acid sodium salt
(Sigma) and 10 mg l- 1 Neutral Red (Sigma, used to colour this
solution in order to check its flow) in 50 mmol l- 1 phosphate
buffer (pH 7.4). The flow of either noradrenaline or
noradrenaline + 3-OHB could be selected by means of a three-
way tap, allowing a rapid change of infusion fluid into the
lower vena cava without a change in the rate of injection or in
the pressure inside the system.
We used an infusion fluid buffered to pH 7.4 to minimize the
negative effects of the infusion on the acid–base equilibrium
of the rat. The noradrenaline solution was prepared freshly for
each rat immediately (5–10 min) before use. Both solutions
(noradrenaline alone and supplemented with 3-OHB) were
prepared in parallel, i.e. noradrenaline was dissolved in a
volume of saline made up with freshly prepared pure water
(Milli-Q quality, Millipore, Bedford, MA, USA); a volume of
stock 3-OHB (brought to pH 7.4) and Neutral Red solution or
plain pure water was then added. Finally, the concentrated
buffer (phosphates, final concentration 50 mmol l- 1) was added
and mixed. The parallel containers were then completely filled
with the twin solutions. At the end of the experiment, one
sample of the infusion solution was taken and frozen after
adding glutathione and internal standard as for the blood
samples. This method was used to determine the degree of
preservation of noradrenaline in the samples. There were no
significant differences in noradrenaline content between the
standards containing 3-OHB and those not containing it. Thelosses of noradrenaline were quite uniform, 5.1±1.7 % (mean
± S.E.M., N=10) for freshly taken samples. Storage time
affected the noradrenaline content (approximately 8 % was lost
over 2 weeks).
The closed system used for storage and delivery of the
infusion fluid prevented its contact with oxygen, thus limiting
noradrenaline oxidation (West, 1952; Hughes and Smith,
1978). Neither the utilization of a thermoneutral chamber
(28–30 °C) nor a neutral pH in the buffered infusion fluid
affected the noradrenaline concentration in the infused solution
for the duration of the experiment and storage.
Rats were anaesthetized and prepared for infusion in
10–13 min; infusion experiments were then carried out in the
heated chamber for a further 60 min.
A group of five rats was infused with 100 mmol l- 1 glucose
instead of noradrenaline, another group of five rats with
1 mol l - 1 3-OHB alone, without noradrenaline; a third group of
five rats was infused with noradrenaline as indicated above, but
the 3-OHB was replaced by 100 mmol l- 1 glucose. Finally, a
group of five additional control rats was infused with 9 g l- 1
NaCl only.
Before the beginning of the infusion procedure, the aortic
temperature of the rats was checked. Even in the heated
chamber, there was a slow tendency to hypothermia caused by
anaesthesia (Sessler, 1991); infusion began when the rat
maintained a temperature of 36 °C for 30 s, thus ensuring an
added degree of uniformity in the responses observed.
Blood samples in this series of rats were limited to
approximately 0.120 ml (every 6 min) in each extraction by
drawing the blood through short pieces of capillary tube used
as blood containers. Blood samples were blown out of the tubes
into small Eppendorf plastic vials; they were centrifuged at
10 000 g for 7 min to obtain plasma. Samples of 75 m l of plasma
were mixed with 675 m l of water, 50 m l of 15 mmol l- 1 reduced
glutathione (Sigma), 50 m l of 90 mmol l- 1 EDTA (Sigma) and
60 m l of 130 nmol l - 1 dihydroxybenzylamine (Sigma, internal
standard). The samples were then shaken (with an orbital mixer
for 30 min at 4 °C) with 20 mg of dry alumina (Merck,
Darmstadt, Germany) and 400 m l of 500 mmol l- 1 Tris–HCl
buffer, pH 8.6. The samples were centrifuged for 10 min at
2000 g at 4 °C. The pellet was resuspended in 1 ml of
3 mmol l- 1 EDTA buffered at pH 7.0 and centrifuged again for
7 min; this washing was repeated three times. The last clean
pellet was resuspended in 150 m l of 200 mmol l- 1 perchloric
acid, shaken for 1 min and then centrifuged for 10 min at 2000 g
at 4 °C. The supernatant was then stored at - 80 °C until used
for noradrenaline estimation.
Blood was withdrawn from a second series of animals in
extractions of 0.050 ml (at 3 min intervals) and then
deproteinized with perchloric acid (Merck); the acid was then
removed with potassium bicarbonate and by centrifugation
(10 000 g for 7 min). The supernatants were stored at - 80 °C
until processed for glucose (Trinder, 1969) and 3-OHB
(Williamson et al. 1962) estimation.
Noradrenaline was determined by using a high-performance
liquid chromatography (HPLC) apparatus (model 1050,
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Fig. 1. Plasma noradrenaline levels in rats infused with noradrenaline
(NA) (filled circles) or noradrenaline + 3-hydroxybutyrate (3-OHB)
(open circles). The data represent the mean ± S.E.M. for 7–8 different
animals. The arrows indicate the period of infusion of 3-OHB (also
marked as a bar at the top of the figure). Significance of the differences
between groups (Student’s t-test): the differences between the
noradrenaline and noradrenaline + 3-OHB groups were significant
only at 24, 30 and 36 min (asterisks).Hewlett-Packard, Palo Alto, CA, USA) fitted with an
electrochemical detector (model 5100A, Coulochem, Bedford,
MA, USA). Samples of 50 m l of purified extracts and standards
were injected into a 15 cm· 0.46 cm column of Spherisorb
ODS2 5 m m (Tecnokroma, Sant Cugat del Vallès, Spain), and
a mobile phase of 100 mmol l- 1 sodium acetate, 40 mmol l- 1
citric acid, 60 mmol l- 1 sodium hydroxide, 5 mmol l- 1 1-octane
sulphonic acid and 100 ml l- 1 methanol, pH 5.2, was run
through at a pressure of 12.4 MPa and a rate of 0.80 ml min- 1
(Mefford et al. 1981). Noradrenaline was eluted as a distinct
peak at 4.5–5 min, adrenaline at 5.5–6 min and
dihydroxybenzylamine at 8.5–9 min. The assay was completed
in 20 min.
Estimation of differences between groups was performed
using standard one- or two-way analysis of variance
(ANOVA), and the Student’s t-test was used for direct
comparison between pairs of groups. The limit of significance
was set at P<0.05.
Results
Plasma noradrenaline levels rose sharply at the beginning of
the infusion and stabilized at approximately 50 nmol l- 1
(Fig. 1), a level that was maintained for up to 60 min. The
presence of 3-OHB in the infusion lowered the levels of
noradrenaline significantly (to approximately 30 nmol l- 1).
Removal of the 3-OHB infusion restored the noradrenaline
levels.
Noradrenaline induced a gradual increase in aortic (core)
temperature to 40–41 °C. The addition of 3-OHB reduced the
rate of temperture increase significantly (Fig. 2A). When 3-
OHB infusion was stopped, the rate of temperature increase
was restored. Infusion of saline resulted in a slow decrease in
core temperature; a similar slow decrease was obtained with
glucose infusion. Infusion of 3-OHB alone (data not shown)
also caused a similar pattern of temperature change. The
replacement of 3-OHB by glucose in noradrenaline-infused
rats had no effect on the rate of increase induced by
noradrenaline alone (data not shown).
The temperature changes observed in the aorta reflected
changes in the temperature of the interscapular BAT. Infusions
of saline, glucose (Fig. 2B) or 3-OHB alone (data not shown)
induced a slow decrease in temperature identical to that of
aortic core temperature. Noradrenaline infusion resulted in an
increase in interscapular BAT temperature to 41–42 °C.
Infusion of 3-OHB and noradrenaline resulted in a marked
slowing of the rate of increase in temperature, an effect that
was maintained after the cessation of 3-OHB infusion.
Substitution of 3-OHB by glucose (data not shown) resulted in
the same pattern as described for noradrenaline alone. The
differences between interscapular BAT and aortic temperature
(i.e. the differential heating induced by BAT) in the rats
infused with noradrenaline and 3-OHB are shown in Fig. 2C;
a temperature difference of up to 2 °C was maintained in
noradrenaline-infused rats up to 45 min of infusion, after which
this difference began to decrease at a comparable rate.Moreover, 3-OHB infusion halted the rise in temperature
differential, an effect that continued after infusion ceased.
3-Hydroxybutyrate levels were not affected by
noradrenaline treatment. Infusion of 3-OHB increased
noradrenaline concentration to above 1 mmol l- 1 (Fig. 3). After
3-OHB infusion ceased, levels fell again to the basal
concentrations.
The curve for the decrease in blood 3-OHB levels after its
infusion ceased was fitted to a decay equation:
H = Ae- Kt ,
where t is time, H is the concentration of 3-OHB, A is a
constant, and K is the decay constant. The half-time for this
process was 4.8 min.
Noradrenaline infusion increased blood glucose
concentration gradually by almost 5 mmol l- 1 in 1 h (Fig. 4).
However, infusion of 3-OHB reversed this effect, first causing
a slow decrease in glucose concentration that then stabilized.
The difference in blood glucose concentration compared with
infusion of noradrenaline alone was almost 4 mmol l- 1.
Discussion
Anaesthesia affects thermoregulation in the rat; its effects
are often associated with a fall in core temperature due to lower
rate of heat production (Ohlson et al. 1992) and a diminished
ability to retain heat, consistent with destabilized temperature
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Fig. 2. Temperature changes in rats infused with noradrenaline (NA)
(filled circles), noradrenaline + 3-OHB (open circles), saline (open
squares) or glucose (filled diamonds). (A) Aortic temperature;
(B) interscapular brown adipose tissue (IBAT) temperature;
(C) difference between IBAT and aortic temperatures ( D T).
Noradrenaline and noradrenaline + 3-OHB data represent the mean
± S.E.M. for 9–10 different animals. Saline and glucose data are the
mean ± S.E.M. for 5–6 different animals. The arrows indicate the
period of infusion of 3-OHB (also marked as a bar at the top of the
figure). Significance of the differences between groups (ANOVA):
(A) there were no differences between the saline- and glucose-
infused groups; the differences between the noradrenaline and
noradrenaline + 3-OHB groups were significant, as were those
between these two groups and the saline and glucose groups;
(B) there were no significant differences between the saline- and
glucose-infused groups; the differences between the noradrenaline
and noradrenaline + 3-OHB groups were significant, as were those
between them and the saline and glucose groups; (C) the differences
between both groups were significant.adjustment mechanisms (Takemoto, 1992). The preparation
used here cushions the fall in body temperature by maintaining
a high environmental temperature. Infusion of saline or saline
supplemented with 3-OHB or glucose elicited neither a rise in
temperature nor an alteration in the basal hypothermic
condition induced by pentobarbital anaesthesia (Sessler, 1991;
Takemoto, 1992).
Most of the alterations to the effects of noradrenaline
described here may be traced to the decrease in circulatingFig. 3. Blood 3-OHB levels of rats infused with noradrenaline (NA)
(filled circles) or noradrenaline + 3-OHB (open circles). The data
represent the mean ± S.E.M. for 7–8 different animals. Arrows indicate
the period of infusion of 3-OHB (also marked as a bar at the top of
the figure). Significance of the differences between groups (Student’s
t-test): the differences between the noradrenaline and noradrenaline +
3-OHB groups were significant only between 22 and 40 min.
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Fig. 4. Blood glucose levels of rats infused with noradrenaline (NA)
(filled circles) or noradrenaline + 3-OHB (open circles). The data
represent the mean ± S.E.M. for 7–8 different animals. Arrows indicate
the period of infusion of 3-OHB (also marked as a bar at the top of
the figure). Significance of the differences between groups (Student’s
t-test): the differences between the noradrenaline and noradrenaline +
3-OHB groups were significant from 28 min onwards.levels of noradrenaline induced by 3-OHB infusion. This
transient effect cannot be reproduced by either saline or
glucose infusion. However, it can explain, at least in part, the
arrest by 3-OHB of temperature increases and the
noradrenaline-induced rise in blood glucose level because,
during 3-OHB infusion, there was less circulating
noradrenaline left to act on BAT and the liver glycogenolytic
pathway.
The observed effects of 3-OHB infusion on the adrenergic
response may be directly related to its concentration in the
plasma, since the maximal effect on BAT temperature
coincides with the highest plasma 3-OHB level, a value close
to the values reached during short-term starvation (Palou et al.
1981) but far below the upper physiological limit attainable
during starvation (Balasse, 1979). The ability of the rat to
remove 3-OHB from the blood was also concentration-
dependent, suggesting that its utilization by peripheral tissues
was enhanced by a fast turnover.
Noradrenaline elicits a significant thermogenic response in
BAT, whose temperature differential from that of the aortic
core was increased. Noradrenaline increases heat production in
BAT (Foster and Frydman, 1978) and other tissues (Ma et al.
1987), thus raising core temperature (Foster and Frydman,
1978), as observed here, by promoting heat storage. The
infusion of 3-OHB strongly influences the effect of
noradrenaline on BAT temperature, i.e. on BAT heat
production. This agrees with its role as a modulator ofadrenergically induced thermogenesis when energy substrates
are scarce, such as during starvation. The effect of 3-OHB on
the stimulation of brown adipocytes by noradrenaline
(Pokasanieva et al. 1993) may be related to its direct effects
on b -adrenergic receptors (De Pergola et al. 1990; Gómez et
al. 1996), but the overall effect is a 3-OHB-induced decrease
in BAT thermogenesis.
Glucose levels increased during noradrenaline infusion, a
direct consequence of generalized glycogenolysis (Shiota et al.
1992). The increase in temperature observed may result in
higher demands for substrates, e.g. glucose, to fuel the
increased thermogenesis, since this is the main substrate for the
BAT thermogenesis that is elicited by noradrenaline or
exposure to cold (Foster and Frydman, 1978, 1979). The slow
rise in blood glucose levels reflects the balance between
noradrenaline-elicited release of glucose from glycogen and its
consumption by BAT and other tissues, which is also in part
dependent on noradrenaline stimulation. The rapid utilization
of infused 3-OHB as an alternative source of energy would
spare glucose and tend to increase glucose levels (Senior and
Loridan, 1968; Amiel et al. 1991). In spite of this sparing of
glucose stores, plasma glucose levels actually decreased in
response to 3-OHB infusion, which suggests that its effects on
glycogenolysis are even more marked than those on glucose
consumption. Thus, it may be assumed that 3-OHB inhibits
noradrenaline-induced glycogenolysis by decreasing the levels
of circulating noradrenaline but also by altering the response
of adrenergic receptors to this hormone (De Pergola et al.
1990; Gómez et al. 1996).
However, the decrease in circulating noradrenaline levels
elicited by 3-OHB is difficult to explain, since the rate of
infusion of noradrenaline did not change throughout the
experiment: a decrease in noradrenaline levels could only be
explained by an increase in its rate of removal/destruction. This
may be due to enhanced disposal of the hormone, which in this
case would be dependent on the concentration of 3-OHB. The
decreased affinity of b -adrenergic receptors for noradrenaline
(De Pergola et al. 1990; Gómez et al. 1996) and the modulation
of central sympathetic brain activity induced by 3-OHB
(Maekubo et al. 1977; Fisler et al. 1995) may contribute to the
role of 3-OHB as an important regulating agent that shows
multiple interactions with noradrenaline within the
physiological concentration range. This interaction may be part
of an elaborate and complex fail-safe mechanism to prevent
wastage of stored substrates.
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